The Role of the Tumor Microenvironment in Triple-Positive Breast Cancer Progression and Therapeutic Resistance

被引:3
|
作者
Pu, Qian [1 ,2 ]
Gao, Haidong [1 ,2 ]
机构
[1] Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Dept Breast Surg, Qingdao 266035, Peoples R China
[2] Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Oncol Lab, Qingdao 266035, Peoples R China
关键词
triple-positive breast cancer; tumor microenvironment; occurrence and development; treatment resistance; ELEVATED AROMATASE EXPRESSION; MAMMARY-GLAND INFLAMMATION; MESENCHYMAL STROMAL CELLS; TRASTUZUMAB RESISTANCE; TAMOXIFEN RESISTANCE; ADIPOSE-TISSUE; STEM-CELLS; FIBROBLASTS; MACROPHAGES; ESTROGEN;
D O I
10.3390/cancers15225493
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary This is an important point of view that the development of breast carcinogenesis is not only related to the intrinsic characteristics of the cancer cells, but that it is also strongly dependent on surrounding microenvironmental factors. It is important to note that triple-positive breast cancer accounts for about 10-15% of all breast cancers, and research on the tumor microenvironment for this subtype is still limited. In this review, authors explored the relationship between critical cellular components and factors in the triple-positive breast cancer microenvironment and the inception, advancement, and therapeutic resistance of breast cancer to provide perspectives on the latest research on triple-positive breast cancer. The authors sufficiently described the state of the art and reported the fundamental concepts, allowing an easy comprehension of the intricate dynamics within tumor microenvironment in triple-positive breast cancer.Abstract Breast cancer (BRCA) is a highly heterogeneous systemic disease. It is ranked first globally in the incidence of new cancer cases and has emerged as the primary cause of cancer-related death among females. Among the distinct subtypes of BRCA, triple-positive breast cancer (TPBC) has been associated with increased metastasis and invasiveness, exhibiting greater resistance to endocrine therapy involving trastuzumab. It is now understood that invasion, metastasis, and treatment resistance associated with BRCA progression are not exclusively due to breast tumor cells but are from the intricate interplay between BRCA and its tumor microenvironment (TME). Accordingly, understanding the pathogenesis and evolution of the TPBC microenvironment demands a comprehensive approach. Moreover, addressing BRCA treatment necessitates a holistic consideration of the TME, bearing significant implications for identifying novel targets for anticancer interventions. This review expounds on the relationship between critical cellular components and factors in the TPBC microenvironment and the inception, advancement, and therapeutic resistance of breast cancer to provide perspectives on the latest research on TPBC.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] A retrospective comparison of the characteristics and recurrence outcome of triple-negative and triple-positive breast cancer
    Randhawa, Jaskirat Singh
    Venur, Vyshak Alva
    Kawsar, Hameem
    Spiro, Timothy Peter
    Haddad, Abdo S.
    Bagai, Rajesh Kumar
    Daw, Hamed
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Drug response-based precision therapeutic selection for tamoxifen-resistant triple-positive breast cancer
    Bisht, Vinod S.
    Kumar, Deepak
    Najar, Mohd Altaf
    Giri, Kuldeep
    Kaur, Jaismeen
    Prasad, Thottethodi Subrahmanya Keshava
    Ambatipudi, Kiran
    JOURNAL OF PROTEOMICS, 2025, 310
  • [23] Cold autoimmune hemolytic anemia: a rare association with triple-positive breast cancer
    Tauseef, Abubakar
    Asghar, Muhammad Sohaib
    Zafar, Maryam
    Ahmed, Iftekhar
    Dawood, Mustafa
    Shaikh, Tooba
    Khan, Narmin
    Alam, Tanveer
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2019, 9 (06): : 499 - 502
  • [24] Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer
    Geng, Anqi
    Xiao, Jingjing
    Dong, Bingyao
    Yuan, Shifang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [25] Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance
    Pu, Zhangya
    Ren, Zhigang
    Xu, Qiuran
    Wang, Xiaochen
    Chen, Jian
    Chen, Jiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] The Tumor Immune Microenvironment in Breast Cancer Progression
    Fjortoft, Marit Otterlei
    Huse, Kanutte
    Rye, Inga Hansine
    ACTA ONCOLOGICA, 2024, 63 : 359 - 367
  • [27] Identification and validation of novel immune genomic subtypes for triple-positive breast cancer
    Zheng, J.
    Qiao, J.
    Zhang, S.
    Zhang, Y.
    Bai, X.
    Cao, J.
    Han, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S433 - S434
  • [28] Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
    Chaudhary, Belal
    Elkord, Eyad
    VACCINES, 2016, 4 (03)
  • [29] Ki-67 and mitotic index in triple-positive breast cancer.
    Urezkova, Maria Mikhailovna
    Semiglazova, Tatiana
    Artemyeva, Anna
    Kudaybergenova, Asel
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
    Zhou, Linlin
    Yu, Chen -Wei
    PHARMACOLOGICAL RESEARCH, 2024, 204